Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Turkalj

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cancers|June 3, 2020
Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell MalignanciesDimitar G Efremov, Sven Turkalj, Luca Laurenti
Hemasphere|June 12, 2023
An Overview of Targeted Therapies in Acute Myeloid LeukemiaSven Turkalj, Felix A Radtke, Paresh Vyas
STAR Protocols|May 23, 2025
Protocol for high-quality RNA sequencing, cell surface protein analysis, and genotyping in single cells using TARGET-seqN Asger Jakobsen, Sven Turkalj, Paresh Vyas
STAR Protocols|October 28, 2023
A protocol for simultaneous high-sensitivity genotyping and chromatin accessibility profiling in single cellsSven Turkalj, Niels Asger Jakobsen, Angus Groom, et al.
Science Immunology|August 23, 2024
Hematopoietic stem cell heterogeneity and age-associated platelet bias are evolutionarily conservedMerve Aksöz, Grigore-Aristide Gafencu, Bilyana Stoilova, et al.
Cell Stem Cell|May 5, 2023
GTAC enables parallel genotyping of multiple genomic loci with chromatin accessibility profiling in single cellsSven Turkalj, Niels Asger Jakobsen, Angus Groom, et al.
Leukemia|March 16, 2019
Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphomaBinu K Sasi, Claudio Martines, Elena Xerxa, et al.
Blood|November 5, 2025
Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapySven Turkalj, Felix A Radtke, Bilyana Stoilova, et al.
Blood Cancer Discovery|April 27, 2023
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid MalignanciesCurtis A Lachowiez, Sanam Loghavi, Zhihong Zeng, et al.
Cell Stem Cell|June 25, 2024
Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and agingNiels Asger Jakobsen, Sven Turkalj, Andy G X Zeng, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancers|June 3, 2020
Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell MalignanciesDimitar G Efremov, Sven Turkalj, Luca Laurenti
Hemasphere|June 12, 2023
An Overview of Targeted Therapies in Acute Myeloid LeukemiaSven Turkalj, Felix A Radtke, Paresh Vyas
STAR Protocols|May 23, 2025
Protocol for high-quality RNA sequencing, cell surface protein analysis, and genotyping in single cells using TARGET-seqN Asger Jakobsen, Sven Turkalj, Paresh Vyas
STAR Protocols|October 28, 2023
A protocol for simultaneous high-sensitivity genotyping and chromatin accessibility profiling in single cellsSven Turkalj, Niels Asger Jakobsen, Angus Groom, et al.
Science Immunology|August 23, 2024
Hematopoietic stem cell heterogeneity and age-associated platelet bias are evolutionarily conservedMerve Aksöz, Grigore-Aristide Gafencu, Bilyana Stoilova, et al.
Cell Stem Cell|May 5, 2023
GTAC enables parallel genotyping of multiple genomic loci with chromatin accessibility profiling in single cellsSven Turkalj, Niels Asger Jakobsen, Angus Groom, et al.
Leukemia|March 16, 2019
Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphomaBinu K Sasi, Claudio Martines, Elena Xerxa, et al.
Blood|November 5, 2025
Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapySven Turkalj, Felix A Radtke, Bilyana Stoilova, et al.
Blood Cancer Discovery|April 27, 2023
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid MalignanciesCurtis A Lachowiez, Sanam Loghavi, Zhihong Zeng, et al.
Cell Stem Cell|June 25, 2024
Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and agingNiels Asger Jakobsen, Sven Turkalj, Andy G X Zeng, et al.
Pageof 2